Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Cash from Operations (2016 - 2021)

Historic Cash from Operations for ENDRA Life Sciences (NDRA) over the last 6 years, with Q4 2021 value amounting to -$2.7 million.

  • ENDRA Life Sciences' Cash from Operations fell 2795.9% to -$2.7 million in Q4 2021 from the same period last year, while for Dec 2021 it was -$11.1 million, marking a year-over-year decrease of 349.68%. This contributed to the annual value of -$7.4 million for FY2024, which is 2249.74% up from last year.
  • As of Q4 2021, ENDRA Life Sciences' Cash from Operations stood at -$2.7 million, which was down 2795.9% from -$2.7 million recorded in Q3 2021.
  • In the past 5 years, ENDRA Life Sciences' Cash from Operations ranged from a high of -$236274.0 in Q1 2017 and a low of -$3.5 million during Q2 2020
  • Over the past 5 years, ENDRA Life Sciences' median Cash from Operations value was -$2.1 million (recorded in 2020), while the average stood at -$2.1 million.
  • In the last 5 years, ENDRA Life Sciences' Cash from Operations plummeted by 93773.16% in 2018 and then soared by 1889.68% in 2021.
  • Over the past 5 years, ENDRA Life Sciences' Cash from Operations (Quarter) stood at -$1.4 million in 2017, then tumbled by 38.3% to -$1.9 million in 2018, then decreased by 0.27% to -$1.9 million in 2019, then decreased by 8.68% to -$2.1 million in 2020, then dropped by 27.96% to -$2.7 million in 2021.
  • Its Cash from Operations was -$2.7 million in Q4 2021, compared to -$2.7 million in Q3 2021 and -$2.8 million in Q2 2021.